Treatment Guideline Resources

Treatment Guideline Resources


U.S. Department of Health and Human Services (DHHS) Treatment Guidelines - All HIV Treatment guidelines from the U.S. Department of Health and Human Services are available online on the AIDSinfo website at http://www.aidsinfo.nih.gov/. These guidelines include: antiretroviral treatment, maternal-child transmission, post-exposure prophylaxis, management of HIV complications, and testing, counseling, and referral.

Below we have summarized the following guidelines and developed others based off of current research and practice: Antiretroviral Therapy in Adults and Adolescents, Antiretroviral Therapy in Pediatrics, Hepatitis C in HIV/AIDS, Opportunistic Infections (OIs) in HIV/AIDS, Post-Exposure Prophylaxis (PEP) in Pediatrics/Adolescents, Post-Exposure Prophylaxis (PEP) Pre-Exposure Prophylaxis (PrEP), Treatment of Tuberculosis (TB) in HIV/AIDS, Treatment of Sexually Transmitted Diseases (STDs) in HIV-Infected Patient and Oral Manifestations Associated with HIV/AIDS.

Antiretroviral Therapy in Adults and Adolescents - October 2012


Highlighting indicates changes made since last update (June 2012). This card is currently being updated to reflect changes in the recently updated guidelines.

This resource summarizes information from the Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Critical information regarding antiretroviral agents currently approved for use in adults and adolescents is included. Information summarized includes adult dosing (including renal and hepatic dosing recommendations), available dosage forms, side effects, and important patient counseling points.
» Request copies by clicking here

Antiretroviral Therapy in Pediatrics - May 2013


Highlighting indicates changes made since last update (October 2012). Pediatric ARV Treatment Guidelines updated November, 2012. Click Here To View

This resource summarizes information from the Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Critical information regarding antiretroviral agents currently approved for use in children is included. Information summarized includes dosing (including renal and hepatic dosing recommendations), available dosage forms, side effects, and important patient counseling points.
» Request copies by clicking here

Hepatitis C in HIV/AIDS - October 2012


Highlighting indicates changes made since last update (June 2012). This card is currently being updated to reflect recent modifications.

This resource is intended to assist clinicians in the diagnosis and management of chronic hepatitis C virus (HCV) infection in HIV-coinfected patients. This guide summarizes guidelines for the detection of HCV infection, evaluation of patients for treatment of chronic HCV infection, contraindications to HCV treatment, and recommendations for HCV treatment in HIV-coinfected patients, including monitoring for response to treatment and management of HCV treatment complications.
» Request copies by clicking here

Opportunistic Infections (OIs) in HIV/AIDS - October 2012


This resource summarizes recommendations from the Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and Adolescents [Centers for Disease Control and Prevention. MMWR 2009;58 (No. RR-4)]. The guide includes both primary and alternative prophylaxis and treatment regimens for selected opportunistic infections. There is a table that includes brand and generic drug names, dosage forms, and food restrictions.
» Request copies by clicking here

Post-Exposure Prophylaxis (PEP) Pre-Exposure Prophylaxis (PrEP) March 2012


Updates in Progress to reflect recent modifications: CDC issues interim guidance on use of medication to prevent HIV infection among heterosexually-active adults. Click Here To View.

This resource summarizes the guidelines for the management of occupational and non-occupational exposures to HIV, hepatitis B, and hepatitis C, including recommendations for post-exposure prophylaxis (PEP). Pre-exposure prophylaxis (PrEP) for the prevention of HIV in men who have sex with men is also summarized. This card is intended to guide decisions about PEP/PrEP and should be used in conjunction with other guidance provided in the full guidelines. View the full guidelines at websites listed throughout card.
» Request copies by clicking here

Post-Exposure Prophylaxis (PEP) in Pediatrics/Adolescents
September 2012


To all users of the F/C AETC Post-Exposure Prophylaxis (PEP) in Pediatrics/Adolescents Treatment Guideline Resource: In the process of reviewing this resource for an update, two errors were found. The errors may impact patient safety and we urge you to destroy any copies you have. To read the full notice of correction click to the right.
Additional updates are currently being made.

This resource was developed to provide guidance on managing potential non-occupational exposures to HIV in pediatrics and adolescents, as there are no official guidelines. Child Protection Teams, schools, youth athletic programs, juvenile justice centers, and other entities that include participation of children and adolescents may find guidance on this topic helpful. Information summarized in this resource includes management of exposures, study findings related to exposure risk, important discussion points when assessing the exposed individual, recommended and alternative antiretroviral (ARV) regimens for PEP of HIV, ARV adverse effects, hepatitis B PEP, and hepatitis C post-exposure management.

Treatment of Tuberculosis (TB) in HIV/AIDS - October 2012


Highlighting indicates changes made since last update (March 2012).

This resource is intended to assist clinicians in the management of HIV-infected patients with latent tuberculosis infection (LTBI) and drug-susceptible tuberculosis infection (TB). This guide summarizes the guidelines for the diagnosis and treatment of LTBI and TB and includes adult dosing, available dosage forms, drug-drug interactions, side effects, and important patient counseling points.
» Request copies by clicking here

Treatment of Sexually Transmitted Diseases (STDs) in HIV-Infected Patients - October 2012


Highlighting indicates changes made since last update (September 2011).

This full-color poster is 22" x 17", and contains photographs of genital and other dermatologic manifestations of sexually transmitted diseases in HIV-infected patients. Each featured STD photograph corresponds with a treatment recommendation, in chart form, based on the Sexually Transmitted Treatment Guidelines, 2010. [Centers for Disease Control and Prevention. MMWR 2010;59(No. RR-12):1-116].
» Request copies by clicking here

Oral Manifestations Associated with HIV/AIDS - May 2013


Highlighting indicates changes made since last update (May 2012).

This 20" x 14" full-color poster has 19 detailed photographs of oral manifestations associated with HIV/AIDS, including the lips, tongue, and mouth. The opposite side lists the agents for treatment of oral manifestations of HIV disease including: antifungal, antiviral, topical, antibacterial, and other treatments.

For more information, please refer to the HIV and Dental Issues Online Training to give you practical information on HIV/AIDS in an on-line, self-study format.

Additional photos of oral manifestations are available at the following website, and can be used for educational purposes. http://www.hivdent.org/_picturegallery_/_picturegallery.htm


» Request copies by clicking here

To get a printed version of any of the resources above e-mail us your name and address. Please indicate quantity and let us know which item(s) you are requesting. A fee may be required for agencies requesting more than a few items.
HRSA
CONTACT US
phone_icon
813.974.4430
fax_icon
813.974.8451
TOLL FREE:  
866.FLC.AETC
352 2382